The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

PSYCHOTOMIMETIC DRUGS AND BRAIN BIOGENIC AMINES

Published Online:https://doi.org/10.1176/ajp.119.9.843

These studies would indicate that the endogenous brain amines are responsive not only to LSD-25 and psychoactive congeners but also to some factor or factors of intense stress. If so, this would provide some biological link between psychoactive drugs, their effects upon amine metabolism and conditions which give rise to the need for such drugs. Perhaps, if endogenous amine mechanisms are chemically or genetically impaired, this could be reflected in altered psychophysiologic function in the face of excessive activation or demand.

These studies refer largely to changes in the rat brain. If we are not to anthropomorphize the rat nor "rodentomorphize" man, our speculation must be limited. Within the rat some psychotomimetic drugs show a pattern of effects on biogenic amines and vice versa. There are little data for the rat which firmly link rates of binding and release within a specific animal with specific patterns of physiological or behavioral response. With respect to psychophysiological effects, these changes in amine levels could conceivably reflect an incidental rather than a necessary and sufficient response to the drug. Differential effects of drugs on amine levels are reliably observed, but for other than time of onset, the changes in levels have not been linked with the pattern of effects. We do not know if the similarity in pattern of amine response to certain stressors and to psychotomimetic drugs reflects similarities in mechanism. Thus, 8 years after Woolley's hypothesis, a relationship of LSD-25 to central amines and certain correlations of amines with autonomic and psychomotor function in the rat and in man can be demonstrated. The mechanisms accountable for these facts and their specific relationship to disturbed patterns of function have not been unraveled, even in the rat.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.